Repurposing existing medications in oncology and their potential role in oral cancer
Date
2019Journal
Oral DiseasesPublisher
Blackwell Publishing LtdType
article
Metadata
Show full item recordIdentifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058073246&doi=10.1111%2fodi.12862&partnerID=40&md5=036c5cdaacdfa7633182135c6ca0c961; http://hdl.handle.net/10713/10182ae974a485f413a2113503eed53cd6c53
10.1111/odi.12862
Scopus Count
Collections
Related articles
- Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.
- Authors: Kobayashi Y, Banno K, Kunitomi H, Tominaga E, Aoki D
- Issue date: 2019 Jan
- Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
- Authors: Saka Herrán C, Jané-Salas E, Estrugo Devesa A, López-López J
- Issue date: 2018 Oct
- [Letter to P. Hammerer. chemoprevention of prostate cancer. Act Urol. 2012; 43].
- Authors: Schmitz-Dräger BJ
- Issue date: 2013 Jan
- Beneficial effects of raloxifene and atorvastatin on serum lipids.
- Authors: Tsakok AD
- Issue date: 2005 Feb
- Advances in the medical management of endometriosis.
- Authors: Panay N
- Issue date: 2008 Jun